NAFLD is generally suspected during routine clinical care when abnormalities are detected in serum aminotransferases (alanine aminotransferase (ALT) and, to a lesser extent, aspartate aminotransferase (AST)) or steatosis is identified through liver imaging (Figure 2) [18,39,40]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.